These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30901310)

  • 1.
    Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
    Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
    Rebouissou S; Franconi A; Calderaro J; Letouzé E; Imbeaud S; Pilati C; Nault JC; Couchy G; Laurent A; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
    Hepatology; 2016 Dec; 64(6):2047-2061. PubMed ID: 27177928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular Adenomas: Morphology and Genomics.
    Bioulac-Sage P; Sempoux C; Balabaud C
    Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
    Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
    Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features.
    Poté N; Caruso S; Caderaro J; Cauchy F; Lagadec F; Couchy G; Raffenne J; Augustin J; Vernuccio F; Vilgrain V; Hercent A; Theou-Anton N; Zucman-Rossi J; Paradis V
    Mod Pathol; 2023 Sep; 36(9):100211. PubMed ID: 37169258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
    Sempoux C; Gouw ASH; Dunet V; Paradis V; Balabaud C; Bioulac-Sage P
    Am J Surg Pathol; 2021 Apr; 45(4):477-487. PubMed ID: 33560657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway.
    Calderaro J; Nault JC; Bioulac-Sage P; Laurent A; Blanc JF; Decaens T; Zucman-Rossi J
    Virchows Arch; 2014 Jan; 464(1):53-60. PubMed ID: 24276407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.
    Evason KJ; Grenert JP; Ferrell LD; Kakar S
    Hum Pathol; 2013 May; 44(5):750-8. PubMed ID: 23084586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
    Zheng J; Sadot E; Vigidal JA; Klimstra DS; Balachandran VP; Kingham TP; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Ventura A
    PLoS One; 2018; 13(7):e0200776. PubMed ID: 30052636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype classification of hepatocellular adenoma.
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2).
    Xu Y; Ge K; Lu J; Huang J; Wei W; Huang Q
    Biomed Pharmacother; 2017 Sep; 93():334-343. PubMed ID: 28651234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
    Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
    Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
    Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
    Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
    Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
    Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
    Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bayard Q; Nault JC; Zucman-Rossi J
    Gut; 2020 Jun; 69(6):1152-1153. PubMed ID: 31154392
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.